Why Attend
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimise performance greater than ever.
Introducing the European Protein Engineering Congress, dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries.
With pharmaceutical, flavour & fragrance, consumer goods, animal feed, and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
Are you tasked with API and natural product synthesis? Why not hear how the industry is applying biosynthetic pathway transfer and multi-model assembly strategies to generate new molecules for industrial purposes?
Are you struggling to craft new enzymes never-before-seen in this century? Hear how ancestral sequence reconstruction, smart-library design, and computer-aided innovation can allow you to discover and generate new and stable active enzymes.
Attend and you'll be able to; increase your product pipeline, increase product efficiency and increase differentiation by meeting the experts in the biocatalysis and protein engineering space.
This is not your average protein engineering congress...it's about industry, sharing knowledge, and optimising your protein engineering method for the best outcomes.
WHO WILL BE THERE
You can expect to meet:
The Speakers
Andreas Liese
Keith Mulholland
Keith was born in and grew up in Liverpool. He obtained his first degree in 1985 at the University of Manchester Institute of Science and Technology, followed by a PhD at the same institution working for Professor Dick Stoodley on C-Nucleoside Synthesis. A Post-Doctoral Fellowship at the University of Texas at Austin working for Professor Philip Magnus on Alkaloid synthesis followed.
He returned to the UK in 1990 to take up a position as a Medicinal Chemist at SmithKline Beecham Harlow working on Serotonin Antagonists for the treatment of Irritable Bowel Syndrome and Depression. In 1996 he moved to the Synthetic Chemistry Department and started work in the area of Process Development.
Following the merger of SmithKline Beecham and Glaxo-Wellcome in 2001, Keith moved to Process R&D AstraZeneca Macclesfield. In his time there he has held various roles. He was the Lead Chemist for the Olaparib project from 2006-2007 and the Catalysis Technology Leader from 2008 to 2011.
Since 2011 he has been the Associate Principal Scientist and Departmental Lead for Biocatalysis within Pharmaceutical Technology and Development.
Doru Roiban
Julien Hitce
Julien Hitce, graduated in France from “Chimie Paris” in 2004, with a Master's degree in Chemical Science. He started his journey into Green Chemistry with his PhD (2004-2007), focused on the development of new methodologies and synthetic applications featuring transition-metal catalyzed transformations, especially C–H activation.
After a postdoctoral stay at Stanford (USA), in the B.M. Trost research group, focused on the development of a novel, enantioselective, atom-economical transformation, he joined L’OREAL Research & Innovation in 2009.
He is currently heading a research group dedicated to the development of new cosmetic ingredients, leveraging the potential of Green Chemistry and innovative transformation technologies for skincare and make-up applications.
Research interests:
- Design and synthesis of novel cosmetic ingredients for skin- and hair-care, with a major focus on Color, Optics and UV-protection
- Green Chemistry with a focus on transformations and processes that straightforwardly generate structural complexity/diversity and added-value from renewable building-blocks
- Process development toward industrialization with a focus on limiting the environmental impact of the process.
“Biocatalysis has emerged as a powerful route toward products that combine both performance and sustainability. And new developments will bring new opportunities: a great promise for green synthesis!”
Cyril Moccand
Helge Bode
Jörn Piel
Donald Hilvert
Reinhard Sterner
Reinhard Sterner studied Biology (Diploma) at the University of Munich (Germany) from where he graduated in 1988. He performed his doctoral studies at the same university and obtained a PhD in 1991 under the supervision of Prof. Heinz Decker. He then moved on to the Biocentre of the University of Basel (Switzerland) where he worked as a postdoctoral fellow with Prof. Kasper Kirschner and completed his Habilitation in Biochemistry in 1996. Reinhard Sterner was then awarded a Heisenberg fellowship from the German Research foundation (DFG), which enabled him in 1997 to set up a junior research group at the University of Göttingen (Germany). In 1999, he was appointed associate professor of Biochemistry at the University of Cologne (Germany). In 2004, he relocated to the University of Regensburg (Germany) where he has been working since then as a full professor of Biochemistry. The main research interests of Prof. Sterner are enzyme engineering, enzyme evolution, and the structure-function relationship of multi-enzyme complexes.
"The engineering of existing enzymes and the design of novel enzymes with a preconceived combination of stability and activity is a highly ambitious and relevant goal of protein biochemistry. Our ability to generate such tailored enzymes would have great implications for our understanding of the structure-function relationship of proteins and holds promise for many medical and biotechnological applications."
Bernhard Hauer
Helen Hailes
Helen received her Ph.D in 1991 at Cambridge under the supervision of Professor Jim Staunton. She pursued post-doctoral work at Cambridge, and then at Imperial College London with Professor Steve Ley and subsequently with Dr David Widdowson. She joined the Department of Chemistry, University College London as a Lecturer in 1994, becoming a Senior Lecturer in 2002, a Reader in 2005, and Professor of Chemical Biology in 2010.
Research is focused on the development of new sustainable chemistry approaches for use in synthesis. Several projects involve the discovery, optimisation and use of biocatalysts in single or multi-step pathways to construct single isomer biologically active molecules. In addition, we are investigating reactions and multi-step synthetic biology cascades in water and other green solvents.
Uwe Bornscheuer
Jennifer Littlechild
Jan von Langermann
Selin Kara
Dörte Rother
Manfred Reetz
Jason Micklefield
Kurt Faber
1973-1979 Studies of chemistry at the University of Graz.
1979 - 82 Thesis in synthetic organic chemistry at the University of Graz. Ph.D. in April 1982.
1982 - 1983: Post-doctoral fellowship at the Memorial University of Newfoundland. Synthesis of porphyrins.
1983 - 1989: University assistant at the Institute of Organic Chemistry, Graz University of Technology.
1990: Habilitation in Organic Chemistry at the Institute of Organic Chemistry, Graz University of Technology. Title: Biocatalytic Transformations.
October 1997, appointment to Associate Professor (C3) at Graz University of Technology.
September 1998, Full Professor at the Institute of Organic Chemistry, University of Graz (C4).
Visiting scientist / guest professor at:
University of Tokyo (1987/1988), Exeter University (1990), University of Trondheim (1994), Stockholm University (2001), University of Minneapolis (2005), ESPCI Paris (2010).
October 2017: Formal retirement, re-employed as senior scientist at the University of Graz.
Eric Eichhorn
Daniel Solis Escalante
Ditte Welner
Hans Iding
Jiří Damborský
Dr Christian Gruber
Thorsten Eggert
Matthew Thompson
Poster Session
Looking to showcase your recent work to the protein engineering community?
Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration). At the congress, your presentation will be displayed in a dedicated poster area. The poster presentation will take place after the lunch break on day one.
Poster submissions are now closed.
Become a Partner
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920, email Duncan Henderson at [email protected] or downloading our agenda and clicking the "Interested in Sponsorship" box below.
Download Agenda
Download the 2019 agenda from the European Protein Engineering Congress:
Register your interest
Senior Event Partner
EnginZyme
Website: http://enginzyme.com/
Everything in nature is produced by enzymes performing reactions inside cells. EnginZyme’s technology platform converts these enzymes into an efficient easy to use catalysts to develop cost efficient enzyme processes to produce a range of chemicals and compounds suitable for pharma, agro, flavour &fragrance, food and chemicals industry. EnginZyme has developed a general enzyme immobilization support, EziG™, a high capacity carrier characterized by predictable, fast and easy immobilization of all enzyme types, without activity loss. When immobilising these enzymes on EziG, it is now possible to perform multi-step cascade reactions in flow in a single packed bed reactor. The EziG cascade cell-free synthetic biology technology is a versatile tool which can be employed to produce a broad range of valuable products, similarly to fermentation but with a more targeted process. Low capital and operating costs are achieved through enzyme reuse and flow operation of the highly active biocatalysts.
Event Partner
Innophore
Website: https://innophore.com/
Innophore uses the patented 3D point cloud technology (so called Catalophores) to identify enzymes for biocatalytic industrial processes.
The search in a proprietary database of active site cavities allows customers to find new enzymes that are otherwise unpredictable.
The platform is a digital search engine for partners in the fields of pharma, chemistry, biotechnology, food, cosmetics, agriculture, textiles or diagnostics.
Artificial intelligence is applied to refine searches and get the most out of our proprietary database.
Protéus by Seqens
Website: https://proteus.seqens.com/
Please visit our website for more information.Zymvol
Website: https://zymvol.com/
Zymvol Biomodeling SL is a privately-owned company based out in Barcelona, Spain.
We are specialized in the discovery and optimization of enzymes for the biocatalytic synthesis of small molecules. We apply proprietary computational technologies that combines bioinformatics, 3D molecular modeling, and Quantum Mechanics to identify and engineering your enzymes in less than 4 weeks. We deliver samples of enzymes identified in any Enzyme Search or In Silico Design campaigns for our clients’ in-house validation. We take into account parameter like activity, selectivity, specificity, stability and solubility.
EnginZyme
Website: http://enginzyme.com/
Everything in nature is produced by enzymes performing reactions inside cells. EnginZyme’s technology platform converts these enzymes into an efficient easy to use catalysts to develop cost efficient enzyme processes to produce a range of chemicals and compounds suitable for pharma, agro, flavour &fragrance, food and chemicals industry. EnginZyme has developed a general enzyme immobilization support, EziG™, a high capacity carrier characterized by predictable, fast and easy immobilization of all enzyme types, without activity loss. When immobilising these enzymes on EziG, it is now possible to perform multi-step cascade reactions in flow in a single packed bed reactor. The EziG cascade cell-free synthetic biology technology is a versatile tool which can be employed to produce a broad range of valuable products, similarly to fermentation but with a more targeted process. Low capital and operating costs are achieved through enzyme reuse and flow operation of the highly active biocatalysts.
Supporting Partner
Twist Biosciences
Website: https://www.twistbioscience.com/
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
Media Partners
Chemical Search International
Website: https://www.chemicalsearch.co.uk/
Chemical Search International specialises exclusively in executive search, talent acquisition and professional career development services for the global chemicals and related sectors such as polymers, materials, natural resources and biosciences. We also own ChemExecSM | Executive Network, an exclusive online professional network dedicated to these same industries and which offers faster, simpler professional networking just when you need it. We have offices in London, New York and Singapore. Please contact us to discuss your company’s recruitment needs or to discuss your own personal career.
ChemExec
Website: https://www.chemicalsearch.co.uk/club/
Chemical Search International specialises exclusively in executive search, talent acquisition and professional career development services for the global chemicals and related sectors such as polymers, materials, natural resources and biosciences. We also own ChemExecSM | Executive Network, an exclusive online professional network dedicated to these same industries and which offers faster, simpler professional networking just when you need it. We have offices in London, New York and Singapore. Please contact us to discuss your company’s recruitment needs or to discuss your own personal career.
Pharma Journalist
Website: http://www.pharmajournalist.com
Pharma Journalist is a leading international B2B magazine providing the global information and the recent updates in the Pharmaceutical Industry.
Our editorial staff works dedicatedly to provide latest information of Pharmaceutical Industry in the form of articles, news, trends, analysis, market report, press releases, whitepapers, case studies, etc. which helps Industry professionals and decision makers to stay on the top of this fast-paced industry.
Various Online marketing services and promotional activities through Pharma Journalist helps companies and organizations to reach their target audience and create brand awareness.
NPRONET
Website: https://npronet.com/
NPRONET will be beneficial to UK industry and society because secondary metabolites, produced predominantly by microorganisms and plants, have inspired the development of many blockbuster drugs including most antibiotics in clinical use.
Natural products are also used in agriculture as herbicides, pesticides and fungicides to increase crop yields which can help feed the growing population.
The network is timely, not only because of the urgent need for new antibiotics but also because of the explosion in genome sequencing is revealing a vast array of new and unexploited biosynthetic gene clusters.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Venue
Radisson Blu Hotel Frankfurt, Franklinstrasse 65, 60486, Frankfurt am Main, Germany
The special rate available for event attendees is €179 (inc. VAT). This rate is for single occupancy and includes breakfast. Please book at least 14 days before your arrival date, 11th November 2019.
Click here to download the booking form. On completion, please send to [email protected].
Please book at least 14 days before your arrival date, 11th November 2019.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
